Holen Sie sich die Stockscreener-App
0.3028
2.23%
0.0066
Handel nachbörslich:
.31
0.0072
+2.38%
Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
8.51%
37.67
|
34.71 | 40.59 | 38.21 | 37.20 |
| Cost Of Revenue |
8.78%
11.57
|
10.64 | 11.12 | 11.91 | 9.857 |
| Gross Profit |
8.40%
26.09
|
24.07 | 29.47 | 26.30 | 27.34 |
| Research and Development |
13.29%
2.702
|
2.385 | - | - | - |
| Costs And Expenses |
2.43%
28.14
|
28.84 | 29.43 | 30.39 | 28.98 |
| Operating Income/Loss |
57.10%
-2.044
|
-4.765 | 0.038 | -4.093 | -1.637 |
| Net Income/Loss |
32.33%
-5.489
|
-8.111 | -2.954 | -17.50 | -2.381 |
| Basic Average Shares |
0.36%
190.34
|
189.65 | 7.183 | 170.35 | 154.02 |
| Diluted Average Shares |
0.36%
190.34
|
189.65 | 7.183 | 170.35 | 154.02 |
| Basic Earnings Per Share |
25.00%
-0.03
|
-0.04 | -0.010 | -0.10 | -0.02 |
| Diluted Earnings Per Share |
25.00%
-0.03
|
-0.04 | -0.010 | -0.10 | -0.02 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):